Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Mishima, Yuko
Item TypeName
Concept Multiple Myeloma
Academic Article [Proteasome inhibitors].
Academic Article Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma.
Academic Article Targeting vasculogenesis to prevent progression in multiple myeloma.
Academic Article Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.
Academic Article The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma.
Academic Article The clonal evolution during long-term clinical course of multiple myeloma.
Academic Article Role of decorin in multiple myeloma (MM) bone marrow microenvironment.
Academic Article Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients.
Academic Article Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination.
Academic Article A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity.
Academic Article Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11.
Academic Article Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.
Academic Article Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.
Academic Article Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.
Academic Article Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma.
Search Criteria
  • Multiple Myeloma